90 related articles for article (PubMed ID: 122404)
1. Pituitary function after removal of pituitary microadenomas in Cushing's disease.
Schnall AM; Brodkey JS; Kaufman B; Pearson OH
J Clin Endocrinol Metab; 1978 Aug; 47(2):410-7. PubMed ID: 122404
[TBL] [Abstract][Full Text] [Related]
2. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
Kuwayama A; Kageyama N; Nakane T; Watanabe M; Kanie N
J Clin Endocrinol Metab; 1981 Jul; 53(1):165-73. PubMed ID: 6263935
[TBL] [Abstract][Full Text] [Related]
3. Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.
Orth DN; DeBold CR; DeCherney GS; Jackson RV; Alexander AN; Rivier J; Rivier C; Spiess J; Vale W
J Clin Endocrinol Metab; 1982 Nov; 55(5):1017-9. PubMed ID: 6288750
[TBL] [Abstract][Full Text] [Related]
4. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
5. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
[TBL] [Abstract][Full Text] [Related]
6. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
7. Cushing's disease: growth hormone response to hypoglycemia after correction of hypercortisolism.
Tyrrell JB; Wiener-Kronish J; Lorenzi M; Brooks RM; Forsham PH
J Clin Endocrinol Metab; 1977 Jan; 44(1):218-21. PubMed ID: 833261
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
9. Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas.
Arafah BM; Kailani SH; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1994 Aug; 79(2):348-54. PubMed ID: 8045946
[TBL] [Abstract][Full Text] [Related]
10. Cushing's disease with cure by resection of a pituitary adenoma. Evidence against a primary hypothalamic defect.
Lagerquist LG; Meikle AW; West CD; Tyler FH
Am J Med; 1974 Nov; 57(5):826-30. PubMed ID: 4374085
[No Abstract] [Full Text] [Related]
11. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
13. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
14. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
16. The definition of true recurrence of pituitary-dependent Cushing's syndrome after transsphenoidal operation.
Lamberts SW; Klijn JG; de Jong FH
Clin Endocrinol (Oxf); 1987 Jun; 26(6):707-12. PubMed ID: 2822299
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma prolactin concentration and pituitary function in patients with a pituitary adenoma.
Hagen C; Lindholm J; Suenson E; Riishede J; Hummer L; Jacobsen HH
Clin Endocrinol (Oxf); 1979 Dec; 11(6):671-9. PubMed ID: 231491
[TBL] [Abstract][Full Text] [Related]
18. Failure of clinical remission after transsphenoidal removal of a microadenoma in a patient with Cushing's disease: multiple hyperplastic and adenomatous cell nets in surrounding pituitary tissue.
Lamberts SW; Stefanko SZ; de Lange SA; Fermin H; van der Vijver JC; Weber RF; de Jong FH
J Clin Endocrinol Metab; 1980 Apr; 50(4):793-5. PubMed ID: 7364932
[TBL] [Abstract][Full Text] [Related]
19. Cushing's disease presenting as pubertal arrest.
Zadik Z; Cooper M; Chen M; Stern N
J Pediatr Endocrinol; 1993; 6(2):201-4. PubMed ID: 8348226
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of Cushing's disease.
Fehm HL; Voigt KH
Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
